{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:24:51Z","timestamp":1787599491020,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01912-8","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:28:10Z","timestamp":1787552890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cardiac protective human circular RNA circKLHL20_009 sponges miR-31-5p to ameliorate myocardial hypertrophy and fibrosis through suppressing \u03b2-catenin signaling"],"prefix":"10.1038","author":[{"given":"Yi-hong","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-ning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-qian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-xin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"1912_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139\u2013e596.","journal-title":"Circulation"},{"key":"1912_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.870924","volume":"9","author":"R Chai","year":"2022","unstructured":"Chai R, Xue W, Shi S, Zhou Y, Du Y, Li Y, et al. Cardiac remodeling in heart failure: role of pyroptosis and its therapeutic implications. Front Cardiovasc Med. 2022;9:870924.","journal-title":"Front Cardiovasc Med"},{"key":"1912_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20517\/2574-1209.2025.165","volume":"10","author":"R Li","year":"2026","unstructured":"Li R, Su X, Jiang J, Su J, Zhu J, Xu J, et al. Circular RNAs as potential therapeutics and novel biomarkers for heart failure. Vessel. 2026;10:35 https:\/\/doi.org\/10.20517\/2574-1209.2025.165.","journal-title":"Vessel"},{"key":"1912_CR4","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1113\/JP278131","volume":"598","author":"FP Kreutzer","year":"2020","unstructured":"Kreutzer FP, Fiedler J, Thum T. Non-coding RNAs: key players in cardiac disease. J Physiol. 2020;598:2995\u20133003.","journal-title":"J Physiol"},{"key":"1912_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/bph.16434","volume":"182","author":"A Bibi","year":"2025","unstructured":"Bibi A, Bartekova M, Gandhi S, Greco S, Mad\u00e8 A, Sarkar M, et al. Circular RNA regulatory role in pathological cardiac remodeling. Br J Pharmacol. 2025;182:316\u201339.","journal-title":"Br J Pharm"},{"key":"1912_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12265-023-10353-1","volume":"16","author":"K Zhang","year":"2023","unstructured":"Zhang K, Li Y, Huang Y, Sun K. PiRNA in cardiovascular disease: focus on cardiac remodeling and cardiac protection. J Cardiovasc Transl Res. 2023;16:768\u201377.","journal-title":"J Cardiovasc Transl Res"},{"key":"1912_CR7","first-page":"3","volume":"10","author":"S Jha","year":"2023","unstructured":"Jha S, Thasma Loganathbabu VK, Kumaran K, Krishnasamy G, Aruljothi KN. Long non-coding RNAs (lncRNAs) in heart failure: a comprehensive review. Noncoding RNA. 2023;10:3.","journal-title":"Noncoding RNA"},{"key":"1912_CR8","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/cells12121629","volume":"12","author":"DD Singh","year":"2023","unstructured":"Singh DD, Kim Y, Choi SA, Han I, Yadav DK. Clinical significance of microRNAs, long non-coding RNAs, and circRNAs in cardiovascular diseases. Cells. 2023;12:1629.","journal-title":"Cells"},{"key":"1912_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116248","volume":"172","author":"A Yaghoobi","year":"2024","unstructured":"Yaghoobi A, Rezaee M, Behnoush AH, Khalaji A, Mafi A, Houjaghan AK, et al. Role of long noncoding RNAs in pathological cardiac remodeling after myocardial infarction: an emerging insight into molecular mechanisms and therapeutic potential. Biomed Pharmacother. 2024;172:116248.","journal-title":"Biomed Pharmacother"},{"key":"1912_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/21541264.2015.1071301","volume":"6","author":"C Huang","year":"2015","unstructured":"Huang C, Shan G. What happens at or after transcription: Insights into circRNA biogenesis and function. Transcription. 2015;6:61\u20134.","journal-title":"Transcription"},{"key":"1912_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1912_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.omtn.2020.06.022","volume":"21","author":"C Zhang","year":"2020","unstructured":"Zhang C, Huo ST, Wu Z, Chen L, Wen C, Chen H, et al. Rapid development of targeting circRNAs in cardiovascular diseases. Mol Ther Nucleic Acids. 2020;21:568\u201376.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1912_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/cvr\/cvz215","volume":"116","author":"H Li","year":"2020","unstructured":"Li H, Xu JD, Fang XH, Zhu JN, Yang J, Pan R, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116:1323\u201334.","journal-title":"Cardiovasc Res"},{"key":"1912_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1161\/CIRCRESAHA.120.318364","volume":"129","author":"WW Du","year":"2021","unstructured":"Du WW, Xu J, Yang W, Wu N, Li F, Zhou L, et al. A neuroligin isoform translated by circNlgn contributes to cardiac remodeling. Circ Res. 2021;129:568\u201382.","journal-title":"Circ Res"},{"key":"1912_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/CIRCRESAHA.117.311335","volume":"122","author":"SK Gupta","year":"2018","unstructured":"Gupta SK, Garg A, B\u00e4r C, Chatterjee S, Foinquinos A, Milting H, et al. Quaking inhibits doxorubicin-mediated cardiotoxicity through regulation of cardiac circular RNA expression. Circ Res. 2018;122:246\u201354.","journal-title":"Circ Res"},{"key":"1912_CR16","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1161\/CIRCRESAHA.119.316061","volume":"127","author":"D Han","year":"2020","unstructured":"Han D, Wang Y, Wang Y, Dai X, Zhou T, Chen J, et al. The tumor-suppressive human circular RNA circITCH sponges miR-330-5p to ameliorate doxorubicin-induced cardiotoxicity through upregulating SIRT6, survivin, and SERCA2a. Circ Res. 2020;127:e108\u201325.","journal-title":"Circ Res"},{"key":"1912_CR17","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857\u201376.","journal-title":"Circulation"},{"key":"1912_CR18","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","volume":"37","author":"K Wang","year":"2016","unstructured":"Wang K, Long B, Liu F, Wang JX, Liu CY, Zhao B, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37:2602\u201311.","journal-title":"Eur Heart J"},{"key":"1912_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15382-x","volume":"11","author":"VNS Garikipati","year":"2020","unstructured":"Garikipati VNS, Verma SK, Cheng Z, Liang D, Truongcao MM, Cimini M, et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS\/VEGF-A axis. Nat Commun. 2020;11:2234.","journal-title":"Nat Commun"},{"key":"1912_CR20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.ymthe.2020.04.006","volume":"28","author":"A Lavenniah","year":"2020","unstructured":"Lavenniah A, Luu TDA, Li YP, Lim TB, Jiang J, Ackers-Johnson M, et al. Engineered circular RNA sponges act as miRNA inhibitors to attenuate pressure overload-induced cardiac hypertrophy. Mol Ther. 2020;28:1506\u201317.","journal-title":"Mol Ther"},{"key":"1912_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41401-025-01620-9","volume":"47","author":"HY Wu","year":"2026","unstructured":"Wu HY, Zhou CM, Gao Y, Wen YH, Hu YT, Zhao HL, et al. circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis. Acta Pharmacol Sin. 2026;47:86\u2013102.","journal-title":"Acta Pharmacol Sin"},{"key":"1912_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9:2629.","journal-title":"Nat Commun"},{"key":"1912_CR23","doi-asserted-by":"publisher","first-page":"19465","DOI":"10.1074\/jbc.274.27.19465","volume":"274","author":"P Fedi","year":"1999","unstructured":"Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP, et al. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem. 1999;274:19465\u201372.","journal-title":"J Biol Chem"},{"key":"1912_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/35083081","volume":"3","author":"A Bafico","year":"2001","unstructured":"Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6\/Arrow. Nat Cell Biol. 2001;3:683\u20136.","journal-title":"Nat Cell Biol"},{"key":"1912_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/35077108","volume":"411","author":"B Mao","year":"2001","unstructured":"Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, et al. LDL-receptor-related protein 6 is a receptor for dickkopf proteins. Nature. 2001;411:321\u20135.","journal-title":"Nature"},{"key":"1912_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108780","volume":"113","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang L, Fan X, Yang W, Yu B, Kou J, et al. Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a\/\u03b2-catenin and Jak2\/Stat3 pathways. Biomed Pharmacother. 2019;113:108780.","journal-title":"Biomed Pharmacother"},{"key":"1912_CR27","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1080\/21655979.2021.1987091","volume":"12","author":"Z Gu","year":"2021","unstructured":"Gu Z, Fang L, Ma P. The angiotensin-converting enzyme inhibitor, captopril, suppressed hepatic stellate cell activation via NF-kappaB or wnt3\u03b1\/\u03b2-catenin pathway. Bioengineered. 2021;12:8370\u20137.","journal-title":"Bioengineered"},{"key":"1912_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","journal-title":"Elife"},{"key":"1912_CR29","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1002\/jcp.25884","volume":"232","author":"S Riaz","year":"2017","unstructured":"Riaz S, Zeidan A, Mraiche F. Myocardial proteases and cardiac remodeling. J Cell Physiol. 2017;232:3244\u201350.","journal-title":"J Cell Physiol"},{"key":"1912_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"1912_CR31","first-page":"1402","volume":"38","author":"WW Du","year":"2017","unstructured":"Du WW, Yang W, Chen Y, Wu ZK, Foster FS, Yang Z, et al. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J. 2017;38:1402\u201312.","journal-title":"Eur Heart J"},{"key":"1912_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12265-022-10228-x","volume":"15","author":"J Guo","year":"2022","unstructured":"Guo J, Chen LW, Huang ZQ, Guo JS, Li H, Shan Y, et al. Suppression of the inhibitory effect of circ_0036176-translated Myo9a-208 on cardiac fibroblast proliferation by miR-218-5p. J Cardiovasc Transl Res. 2022;15:548\u201359.","journal-title":"J Cardiovasc Transl Res"},{"key":"1912_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3724\/abbs.2025033","volume":"57","author":"Q Wang","year":"2025","unstructured":"Wang Q, Hou J, Zeng S, Wang X, Liang Y, Zhou R. METTL3-mediated m6A modification of pri-miRNA-31 promotes hypertrophic scar progression. Acta Biochim Biophys Sin. 2025;57:1106\u201314.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1912_CR34","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00210-020-01847-9","volume":"393","author":"H Li","year":"2020","unstructured":"Li H, Shi H, Zhang F, Xue H, Wang L, Tian J, et al. LncRNA Tincr regulates PKC\u025b expression in a miR-31-5p-dependent manner in cardiomyocyte hypertrophy. Naunyn Schmiedeb Arch Pharmacol. 2020;393:2495\u2013506.","journal-title":"Naunyn Schmiedeb Arch Pharm"},{"key":"1912_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18413","volume":"28","author":"L Zhao","year":"2024","unstructured":"Zhao L, Qian X, Ren Z, Wang A. miR-31-5p suppresses myocardial hypertrophy by targeting Nfatc2ip. J Cell Mol Med. 2024;28:e18413.","journal-title":"J Cell Mol Med"},{"key":"1912_CR36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7150\/jca.11735","volume":"6","author":"Z Ye","year":"2015","unstructured":"Ye Z, Jin H, Qian Q. Argonaute 2: a novel rising star in cancer research. J Cancer. 2015;6:877\u201382.","journal-title":"J Cancer"},{"key":"1912_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1157043","volume":"14","author":"B Ni","year":"2023","unstructured":"Ni B, Sun M, Zhao J, Wang J, Cao Z. The role of \u03b2-catenin in cardiac diseases. Front Pharmacol. 2023;14:1157043.","journal-title":"Front Pharmacol"},{"key":"1912_CR38","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.110.223768","volume":"107","author":"MW Bergmann","year":"2010","unstructured":"Bergmann MW. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res. 2010;107:1198\u2013208.","journal-title":"Circ Res"},{"key":"1912_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/HYPERTENSIONAHA.109.141127","volume":"55","author":"P Malekar","year":"2010","unstructured":"Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS, et al. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension. 2010;55:939\u201345.","journal-title":"Hypertension"},{"key":"1912_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13912","volume":"237","author":"VV Balatskyi","year":"2023","unstructured":"Balatskyi VV, Sowka A, Dobrzyn P, Piven OO. The WNT\/\u03b2-catenin pathway is a key regulator of cardiac function and energetic metabolism. Acta Physiol. 2023;237:e13912.","journal-title":"Acta Physiol"},{"key":"1912_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7:78.","journal-title":"Signal Transduct Target Ther"},{"key":"1912_CR42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41401-024-01415-4","volume":"46","author":"L Pan","year":"2025","unstructured":"Pan L, Yin C, Jin KJ, Huang CX, Wang X, Wang Y, et al. Low-density lipoprotein receptor-related protein 6 ameliorates cardiac hypertrophy by regulating CTSD\/HSP90\u03b1 signaling during pressure overload. Acta Pharmacol Sin. 2025;46:606\u201317.","journal-title":"Acta Pharmacol Sin"},{"key":"1912_CR43","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7150\/thno.48787","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Zou Y, Chen Z, Li Y, Pan L, Wang Y, et al. Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis. Theranostics. 2021;11:1249\u201368.","journal-title":"Theranostics"},{"key":"1912_CR44","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s12015-022-10385-1","volume":"18","author":"L Zhu","year":"2022","unstructured":"Zhu L, Liu K, Feng Q, Liao Y. Cardiac organoids: a 3D technology for modeling heart development and disease. Stem Cell Rev Rep. 2022;18:2593\u2013605.","journal-title":"Stem Cell Rev Rep"},{"key":"1912_CR45","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.7150\/thno.67661","volume":"12","author":"J Cho","year":"2022","unstructured":"Cho J, Lee H, Rah W, Chang HJ, Yoon YS. From engineered heart tissue to cardiac organoid. Theranostics. 2022;12:2758\u201372.","journal-title":"Theranostics"},{"key":"1912_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13631","volume":"57","author":"J Yang","year":"2024","unstructured":"Yang J, Lei W, Xiao Y, Tan S, Yang J, Lin Y, et al. Generation of human vascularized and chambered cardiac organoids for cardiac disease modelling and drug evaluation. Cell Prolif. 2024;57:e13631.","journal-title":"Cell Prolif"},{"key":"1912_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.omtn.2021.10.013","volume":"26","author":"N Zeng","year":"2021","unstructured":"Zeng N, Huang YQ, Yan YM, Hu ZQ, Zhang Z, Feng JX, et al. Diverging targets mediate the pathological role of miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis. Mol Ther Nucleic Acids. 2021;26:1035\u201350.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1912_CR48","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.bbrc.2019.09.035","volume":"519","author":"G Song","year":"2019","unstructured":"Song G, Zhu L, Ruan Z, Wang R, Shen Y. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3. Biochem Biophys Res Commun. 2019;519:682\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1912_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbrc.2019.09.107","volume":"521","author":"J Cui","year":"2020","unstructured":"Cui J, Qi S, Liao R, Su D, Wang Y, Xue S. MiR-574-5p promotes the differentiation of human cardiac fibroblasts via regulating ARID3A. Biochem Biophys Res Commun. 2020;521:427\u201333.","journal-title":"Biochem Biophys Res Commun"},{"key":"1912_CR50","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012710","volume":"13","author":"J Wu","year":"2021","unstructured":"Wu J, Venkata Subbaiah KC, Jiang F, Hedaya O, Mohan A, Yang T, et al. MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling. EMBO Mol Med. 2021;13:e12710.","journal-title":"EMBO Mol Med"},{"key":"1912_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173374","volume":"883","author":"JJ Song","year":"2020","unstructured":"Song JJ, Yang M, Liu Y, Song JW, Wang J, Chi HJ, et al. MicroRNA-122 aggravates angiotensin II-mediated apoptosis and autophagy imbalance in rat aortic adventitial fibroblasts via the modulation of SIRT6-elabela-ACE2 signaling. Eur J Pharmacol. 2020;883:173374.","journal-title":"Eur J Pharm"},{"key":"1912_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153481","volume":"83","author":"W Feng","year":"2021","unstructured":"Feng W, Ying Z, Ke F, Mei-Lin X. Apigenin suppresses TGF-\u03b21-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1\u03b1 expression by miR-122-5p. Phytomedicine. 2021;83:153481.","journal-title":"Phytomedicine"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01912-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01912-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01912-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:02:36Z","timestamp":1787598156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01912-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":52,"alternative-id":["1912"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01912-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}